Literature DB >> 9357344

Excess mortality attributable to hip fracture in white women aged 70 years and older.

J Magaziner1, E Lydick, W Hawkes, K M Fox, S I Zimmerman, R S Epstein, J R Hebel.   

Abstract

OBJECTIVE: The purpose of this study was to estimate the excess mortality attributable to hip fracture.
METHODS: The 6-year survival rate of community-dwelling White female hip fracture patients aged 70 years and older entering one of seven hospitals from 1984 to 1986 (n = 578) was compared with that of White female respondents aged 70 years and older interviewed in 1984 for the Longitudinal Study on Aging (n = 3773).
RESULTS: After age, education, comorbidity, and functional impairment were controlled, the mortality differential between the two groups accumulated to an excess among hip fracture patients of 9 deaths per 100 women 5 years postfracture. Among those with three or more functional impairments or one or more comorbidities, the excess was 7 deaths per 100: the effect of the fracture had disappeared in these groups by 4 years. In contrast, those with two or fewer impairments and those with no comorbidities had a continuing trend of increased mortality, with an excess of 14 deaths per 100 by 5 years.
CONCLUSIONS: There is an immediate increase in mortality following a hip fracture in medically ill and functionally impaired patients, whereas among those with no comorbidities and few impairments, there is a gradual increase in mortality that continues for 5 years postfracture.

Entities:  

Mesh:

Year:  1997        PMID: 9357344      PMCID: PMC1381125          DOI: 10.2105/ajph.87.10.1630

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  34 in total

1.  Survival experience of aged hip fracture patients.

Authors:  J Magaziner; E M Simonsick; T M Kashner; J R Hebel; J E Kenzora
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

2.  Rate of mortality for elderly patients after fracture of the hip in the 1980's.

Authors:  B L White; W D Fisher; C A Laurin
Journal:  J Bone Joint Surg Am       Date:  1987-12       Impact factor: 5.284

3.  Long-term follow-up of hip fractures.

Authors:  P L McCown; W A Miller
Journal:  South Med J       Date:  1976-12       Impact factor: 0.954

4.  Mortality and life expectancy after hip fractures.

Authors:  E Dahl
Journal:  Acta Orthop Scand       Date:  1980-02

5.  Hip fracture among the elderly in a mixed urban and rural population.

Authors:  J Kreutzfeldt; M Haim; E Bach
Journal:  Age Ageing       Date:  1984-03       Impact factor: 10.668

6.  Mortality after hip fractures.

Authors:  J S Jensen; E Tøndevold
Journal:  Acta Orthop Scand       Date:  1979-04

7.  Mortality in women following hip fracture.

Authors:  N S Weiss; J M Liff; C L Ure; J H Ballard; G H Abbott; J R Daling
Journal:  J Chronic Dis       Date:  1983

8.  Survival and ambulation following hip fracture.

Authors:  C W Miller
Journal:  J Bone Joint Surg Am       Date:  1978-10       Impact factor: 5.284

9.  Patient-proxy response comparability on measures of patient health and functional status.

Authors:  J Magaziner; E M Simonsick; T M Kashner; J R Hebel
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

10.  Mortality after cervical hip fracture. 3002 patients followed for 6 years.

Authors:  S Holmberg; P Conradi; R Kalén; K G Thorngren
Journal:  Acta Orthop Scand       Date:  1986-02
View more
  77 in total

1.  Hip fracture and increased short-term but not long-term mortality in healthy older women.

Authors:  Erin S LeBlanc; Teresa A Hillier; Kathryn L Pedula; Joanne H Rizzo; Peggy M Cawthon; Howard A Fink; Jane A Cauley; Douglas C Bauer; Dennis M Black; Steven R Cummings; Warren S Browner
Journal:  Arch Intern Med       Date:  2011-09-26

2.  Editorial: Improving end of life care in orthopaedics.

Authors:  Mark D Neuman
Journal:  Clin Orthop Relat Res       Date:  2011-03       Impact factor: 4.176

3.  Excess mortality after hip fracture among elderly women in Norway. The HUNT study.

Authors:  A B Grønskag; P Romundstad; S Forsmo; A Langhammer; B Schei
Journal:  Osteoporos Int       Date:  2011-11-09       Impact factor: 4.507

4.  Three-dimensional X-ray absorptiometry (3D-XA): a method for reconstruction of human bones using a dual X-ray absorptiometry device.

Authors:  S Kolta; A Le Bras; D Mitton; V Bousson; J A de Guise; J Fechtenbaum; J D Laredo; C Roux; W Skalli
Journal:  Osteoporos Int       Date:  2004-12-14       Impact factor: 4.507

5.  Mortality within 1 year after hip fracture surgical repair in the elderly according to postoperative period: a probabilistic record linkage study in Brazil.

Authors:  E I O Vidal; C M Coeli; R S Pinheiro; K R Camargo
Journal:  Osteoporos Int       Date:  2006-07-27       Impact factor: 4.507

6.  The relationship between historical risk-adjusted 30-day mortality and subsequent hip fracture outcomes: Retrospective cohort study.

Authors:  Mark D Neuman; Molly R Passarella; Rachel M Werner
Journal:  Healthc (Amst)       Date:  2015-10-30

7.  Reduced morbidity for elderly patients with a hip fracture after implementation of a perioperative evidence-based clinical pathway.

Authors:  L A Beaupre; J G Cinats; A Senthilselvan; D Lier; C A Jones; A Scharfenberger; D W C Johnston; L D Saunders
Journal:  Qual Saf Health Care       Date:  2006-10

8.  Utilization of inpatient care before and after hip fracture: a population-based study.

Authors:  E Lönnroos; H Kautiainen; R Sund; P Karppi; S Hartikainen; I Kiviranta; R Sulkava
Journal:  Osteoporos Int       Date:  2008-09-23       Impact factor: 4.507

Review 9.  Fracture mortality: associations with epidemiology and osteoporosis treatment.

Authors:  Sebastian E Sattui; Kenneth G Saag
Journal:  Nat Rev Endocrinol       Date:  2014-08-05       Impact factor: 43.330

10.  Predictors of bone loss after hip fracture.

Authors:  Lois E Wehren; William G Hawkes; J Richard Hebel; Denise Orwig; Sheryl I Zimmerman; Kathleen M Fox; Janet Yu-Yahiro; Jay Magaziner
Journal:  Osteoporos Int       Date:  2003-12-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.